Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
A patient with ACTH-dependent Cushing's syndrome remained in clinical and biochemical remission six years after pituitary irradiation and while on bromocriptine therapy. When bromocriptine was discontinued urinary free cortisol values became elevated, and were not suppressed by dexamethasone. After reintroduction of the drug, remission was again obtained. It is concluded that bromocriptine is responsible for continuing longterm remission in this case. The possible use of bromocriptine as an adjunctive therapy in ACTH-dependent Cushing's syndrome is discussed.
Atkinson
A B
AB
Kennedy
A L
AL
Sheridan
B
B
D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism*; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000532:radiotherapy; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008134:Long-Term Care; D008297:Male; D010902:Pituitary Gland / Q000528:radiation effects
D001971:Bromocriptine; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone